Forbes March 4, 2024
Walgreens Boots Alliance chief executive officer Tim Wentworth said the company won’t sell its fast-growing Shields specialty pharmacy
A three-byline Bloomberg News story in January said the embattled drugstore chain was “exploring options including a sale of Shields Health Solutions, the specialty pharmacy business it acquired a majority of three years ago.” The business could be valued at more than $4 billion, Bloomberg reported,
But Wentworth, who has been on the job as Walgreens CEO for four months now, swatted down that theory, saying Shields is a key part of the company’s growth strategy. Shields works with hospitals and health systems to set up and run their own on-site specialty pharmacies.
“We love working with health systems and Shields is...
Today's Sponsors
Today's Sponsor